A phase 1/2 ascending dose study and open-label extension study of voxelotor in patients with sickle cell disease
- Submitting institution
-
Queen Mary University of London
- Unit of assessment
- 1 - Clinical Medicine
- Output identifier
- 1959
- Type
- D - Journal article
- DOI
-
10.1182/blood-2018-08-868893
- Title of journal
- Blood
- Article number
- -
- First page
- 1865
- Volume
- 133
- Issue
- 17
- ISSN
- 0006-4971
- Open access status
- Compliant
- Month of publication
- April
- Year of publication
- 2019
- URL
-
-
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
15
- Research group(s)
-
A - Blizard
- Citation count
- 37
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- PT helped design the study for patients with SCD, referred patients with SCD, and reviewed and provided input into the manuscript writing
- Non-English
- No
- English abstract
- -
